Chemokines in lupus nephritis

被引:0
作者
Kulkarni, Onkar [1 ,2 ]
Anders, Hans-Joachim [1 ,2 ]
机构
[1] Univ Munchen Klinikum, Med Poliklin, Dept Nephrol, Munich, Germany
[2] Univ Munchen Klinikum, Med Poliklin, Dept Rheumatol, Munich, Germany
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2008年 / 13卷
关键词
chemokine; chemokine receptors; systemic lupus erythematosus; lupus nephritis; leukocyte recruitment; kidney; review;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lupus nephritis is a common solid organ manifestation of systemic lupus erythematosus (SLE). The disease is tightly linked to the production of autoantibodies and circulating immune complexes, i.e. immune complex glomerulonephritis. In this process chemokines mediate multiple biological effects, e. g. orchestrating proinflammatory microenvironments, the recruitment of immune cell subsets into the kidney, as well as the local activation of such immune effector cells. Autoimmune mice with targeted deletions of certain single chemokines or chemokine receptors are protected from renal autoimmune tissue injury. Interventional studies with specific antagonists against certain chemokines and chemokine receptors further support these findings. In this review we summarise the available experimental and human data on the expression and functional role of chemokines and chemokine receptors in lupus nephritis.
引用
收藏
页码:3312 / 3320
页数:9
相关论文
共 75 条
[1]  
Aguilar F, 2003, J RHEUMATOL, V30, P1770
[2]   MCP-1 promoter polymorphism in Spanish patients with systemic lupus erythematosus [J].
Aguilar, F ;
González-Escribano, MF ;
Sánchez-Román, J ;
Núñez-Roldán, A .
TISSUE ANTIGENS, 2001, 58 (05) :335-338
[3]   Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice [J].
Anders, HJ ;
Belemezova, E ;
Eis, V ;
Segerer, S ;
Vielhauer, V ;
De Lema, GP ;
Kretzler, M ;
Cohen, CD ;
Frink, M ;
Horuk, R ;
Hudkins, KL ;
Alpers, CE ;
Mampaso, F ;
Schlöndorff, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06) :1504-1513
[4]   Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice [J].
Anders, HJ ;
Vielhauer, V ;
Eis, V ;
Linde, Y ;
Kretzler, M ;
de Lema, GP ;
Strutz, F ;
Bauer, S ;
Rutz, M ;
Wagner, H ;
Gröne, HJ ;
Schlbndorff, D .
FASEB JOURNAL, 2004, 18 (01) :534-+
[5]   CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration [J].
Anders, HJ ;
Frink, M ;
Linde, Y ;
Banas, B ;
Wörnle, M ;
Cohen, CD ;
Vielhauer, V ;
Nelson, PJ ;
Gröne, HJ ;
Schlöndorff, D .
JOURNAL OF IMMUNOLOGY, 2003, 170 (11) :5658-5666
[6]   Chemokines and chemokine receptors are involved in the resolution or progression of renal disease [J].
Anders, HJ ;
Vielhauer, V ;
Schlöndorff, D .
KIDNEY INTERNATIONAL, 2003, 63 (02) :401-415
[7]   Bacterial CpG-DNA aggravates immune complex glomerulonephritis:: Role of TLR9-mediated expression of chemokines and chemokine receptors [J].
Anders, HJ ;
Banas, B ;
Linde, Y ;
Weller, L ;
Cohen, CD ;
Kretzler, M ;
Martin, S ;
Vielhauer, V ;
Schlöndorff, D ;
Gröne, HJ .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :317-326
[8]  
Anders HJ, 2001, J AM SOC NEPHROL, V12, P919, DOI 10.1681/ASN.V125919
[9]   Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus [J].
Balabanian, K ;
Couderc, J ;
Bouchet-Delbos, L ;
Amara, A ;
Berrebi, D ;
Foussat, A ;
Baleux, FO ;
Portier, A ;
Durand-Gasselin, I ;
Coffman, RL ;
Galanaud, P ;
Peuchmaur, M ;
Emilie, D .
JOURNAL OF IMMUNOLOGY, 2003, 170 (06) :3392-3400
[10]   Increased severity of glomerulonephritis in C-C chemokine receptor 2 knockout mice [J].
Bird, JE ;
Giancarli, MR ;
Kurihara, T ;
Kowala, MC ;
Valentine, MT ;
Gitlitz, PH ;
Pandya, DG ;
French, MH ;
Durham, SK .
KIDNEY INTERNATIONAL, 2000, 57 (01) :129-136